Tamoxifen belongs among relatively new drugs. As it has already been shown,
it undoubtedly brings a benefit to oncology patients. However, there are s
till questions regarding its broader use in therapy or cancer prevention. T
his review puts together some data available at present time with the aim o
f elucidating the most important aspects of its use in medical oncology.